DIGIASIA Corp Advances into AI Solutions for Financial Services, Telecom, and Government Sectors with NVIDIA GPU Allocation

~ Initial Access to 5,120 of NVIDIA’s Latest and Most Powerful GPUs ~

~ Develop and Deploy Advanced AI Enterprise Solutions for Fintech, Telecom, and Governments, Leveraging DIGIASIA’s Existing Infrastructure and NVIDIA’s Superior Hardware ~

~ Significant Expansion of DIGIASIA’s Comprehensive “Fintech as a Service” Ecosystem, Tapping into an Estimated USD 200–300 Billion Annual Global Opportunity for AI Across Financial Services1 ~

~ Catalyst to Achieve Significant Growth of Top and Bottom Line Beginning in the Fourth Quarter of 2024 ~

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) — Digi Tech Limited, the UAE based subsidiary of DIGIASIA Corp. (NASDAQ: FAAS) (“DIGIASIA” or the “Company”), a leading Fintech as a Service (“FaaS”) ecosystem provider, has secured allocation of an initial tranche of 5,120 NVIDIA H200 GPUs (NASDAQ: NVDA). The access to NVIDIA’s GPUs will propel DIGIASIA’s development of cutting–edge AI solutions for enterprise customers in fintech, telecom, and government sectors. The first iteration of these NVIDIA–powered solutions is expected to be deployed by the fourth quarter of 2024. DIGIASIA will base operations for its AI initiatives out of the Dubai International Financial Center (“DIFC”) in the UAE leveraging on the UAE and the DIFC’s global leadership in the advancement of advanced AI solutions.

Structure of Transaction and AI Fintech Platform

DIGIASIA has been allocated an initial tranche of 5,120 NVIDIA H200 GPUs with the option for an additional 10,240 GPUs. The total market value of the initial tranche exceeds $400 million and exceeds $1.2 billion with the additional option. Initially, DIGIASIA will deploy these advanced GPUs in Southeast Asia, India, and the Middle East, with plans for global expansion.

The integration of NVIDIA’s GPUs will significantly enhance DIGIASIA’s fintech infrastructure, boosting productivity and efficiency. This will enable DIGIASIA enterprise clients to implement advanced solutions such as AML, fraud detection, KYC, smart dealer lending, branchless banking, automated customer journeys, and deep encryption of financial data.

Market Opportunity

DIGIASIA’s access to NVIDIA GPUs opens up a substantial market opportunity, potentially tapping into a USD 200–300 billion annual global market in financial services. By leveraging NVIDIA’s cutting–edge GPUs and AI models, DIGIASIA aims to deliver advanced AI fintech solutions across Southeast Asia, India and the Middle East. DIGIASIA plans to utilize its existing enterprise partners and identify incremental strategic partners for AI datacenter hosting to support these innovative solutions.

Executive Insights

Prashant Gokarn, CEO of DIGIASIA, stated, “NVIDIA GPUs are at the core of any AI–based solution. We are thrilled with this allocation, which allows us to develop the next generation of DIGIASIA’s embedded finance platform with generative AI, enhancing precision and productivity for enterprises. This will allow us to continue to support our existing and new enterprise customers in the AI revolution.”

Subir Lohani, CFO and Chief Strategy Officer of DIGIASIA, commented, “Since going public in April, we have consistently executed our strategy to provide innovative solutions to our enterprise clients and expand our geographic reach. We plan to roll out the initial NVIDIA–powered solutions by the fourth quarter of 2024, driving significant growth and attractive returns. We are excited to grow this initiative from the DIFC Innovation Hub / AI Campus in the UAE which has become a global hub for the advancement of AI solutions.”

Forward–Looking Statements:

This press release may contain forward–looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe”, “expect”, “anticipate”, “project”, “targets”, “optimistic”, “confident that”, “continue to”, “predict”, “intend”, “aim”, “will” or similar expressions are intended to identify forward–looking statements. All statements other than statements of historical fact are statements that may be deemed forward–looking statements. These forward–looking statements including, but not limited to, statements concerning DIGIASIA and the Company’s operations, financial performance and condition are based on current expectations, beliefs and assumptions which are subject to change at any time. DIGIASIA cautions that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors such as government and stock exchange regulations, competition, political, economic and social conditions around the world including those discussed in DIGIASIA’s Form 20–F under the headings “Risk Factors”, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Business Overview” and other reports filed with the Securities and Exchange Commission from time to time. All forward–looking statements are applicable only as of the date it is made and DIGIASIA specifically disclaims any obligation to maintain or update the forward–looking information, whether of the nature contained in this release or otherwise, in the future.

Investor Contact:

MZ North America

Email: FAAS@mzgroup.us

Company Contact:

Subir Lohani

Chief Strategy Officer and CFO

Email: subir.lohani@digiasia.asia 


GLOBENEWSWIRE (Distribution ID 9168558)

LNC DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Lincoln National Corporation Investors to Secure Counsel Before Important June 24 Deadline in Securities Class Action – LNC

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lincoln National Corporation (NYSE: LNC) between November 4, 2020 and November 2, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Lincoln National securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Lincoln National class action, go to https://rosenlegal.com/submit–form/?case_id=24462 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 24, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Lincoln National was experiencing a decline in its variable universal life insurance business; (2) as a result, the goodwill associated with the life insurance business was overstated; (3) as a result, Lincoln National’s policy lapse assumptions were outdated; (4) as a result, Lincoln National’s reserves were overstated; (5) as a result, Lincoln National’s reported financial results and financial statements were misstated; and (6) as a result of the foregoing, defendants’ positive statements about Lincoln National’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Lincoln National class action, go to https://rosenlegal.com/submit–form/?case_id=24462 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email case@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686–1060
        Toll Free: (866) 767–3653
        Fax: (212) 202–3827
        case@rosenlegal.com
        www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 9168343)

The Age of Holy War & Poetics of Solidarity – (Part 1)

Credit: Office of the High Commissioner for Human Rights (OHCHR)

By Azza Karam
NEW YORK, Jun 24 2024 – “Holy War” is how the Patriarch of the Russian Orthodox Church referred to the Russian war on the Ukraine, and indeed, on “the West”1 . “Holy War”, aka “jihad” is a foundational principle of “the Base” or “al-Qaeda”, which has grown into a non-state hydra with too many names and atrocities to list here (but if you are curious, one of the hydra faces is ISIS).

In a recent opinion piece published in Foreign Policy, columnist Caroline de Gruyter noted that “Israel and Palestine Are Now in a Religious War”, in her attempt to argue why the Middle East conflict has been getting increasingly brutal, and increasingly hard to solve.

The intersection between holiness and war is even more nuanced in Zvi Bar’el’s Opinion piece in Haaretz, when he notes that “the war in Gaza is no longer about revenge for the murder of 1,200 Israelis or the hostages.

If they all die, along with hundreds of more soldiers, the price would still be justified for the Jewish Jihad waging a war for Gaza’s resettlement” [emphasis added]. Hamas’ own name –the acronym for Harakat al-Muqawama al-Islamiya (Islamic Resistance Movement) – needs no elaboration. Neither does Lebanon’s Hizbullah (Party of God).

In India, a report by the Indian Citizens and Lawyers Initiative (in April of 2023), entitled “Routes of Wrath: Weaponising Religious Processions”, notes

Indian history is rife with instances of religious processions that led to communal strife, riots, inexcusable violence, arson, destruction of property and the tragic deaths of innocent residents of the riot-hit areas. There have been horrific riots and bloodletting caused by other factors too, most prominently the anti-Sikh pogrom of 1984 and the Gujarat pogrom of 2002, but no cause of interfaith riots has been as recurrent and widespread as the religious procession. This is as true of pre-Independence India as during the 75 years since we became a free nation…Post-Independence, we have faced numerous communal riots in diverse parts of India, under different political regimes, and the vast majority of these have been caused by the deliberate choice of communally-sensitive routes by processionists, and the pusillanimity of the Police in dealing with such demands, or even their collusion and connivance in licencing such routes.2

Already back in August of 1988, in an article entitled “Holy War Against India”, explicitly speaks of “Sikh terrorism” in the Punjab, noting that it “took about a thousand lives in 1987 and more than a thousand in the first five months of 1988.

If it continues at the present rate, Sikh terrorism in the Punjab will have cost more lives in two years than the IRA campaign in Northern Ireland has cost in twenty.” 3 Speaking of Northern Ireland, the marching season remains a flashpoint among Catholics and Protestants.

Politicised religion, or religionised politics – whence religious discourse is part of political verbiage, tactics, expedient alliances, sometimes informing foreign policy priorities, occasionally used to justify conflict – are not new phenomena. In fact, they may well be one of the oldest features of politics, governance – and warmaking.

The Crusades against Muslim expansion in the 11th century were recognized as a “holy war” or a bellum sacrum, by later writers in the 17th century. The early modern wars against the Ottoman Empire were seen as a seamless continuation of this conflict by contemporaries. Religion and politics are the oldest bedfellows known to humankind.

What is relatively new, is that after the 100-year war in Europe, and the subsequent moves towards secularisation or the so-called ‘separation of Church and State’ (again, really only in parts of Europe), provided a false sense of the dominance of secular governance in modern times.

Yet, even in the citadels of secular Western Europe, a relationship binding Church and State always existed, for the religious institutions and their affiliated social structures, remain critical social service providers – and humanitarian actors – till today. A reality now understood to be relevant in all parts of our world.

Nevertheless, what we are seeing today is a resurgence of religious politics, and the politics of religion, in almost all corners of the world. Before the Russian Orthodox Church proclaimed its “holy war” narrative, the reference to religion and politics almost always focused on Muslim-majority contexts, specifically on Iran, Saudi Arabia and Afghanistan.

Other realities would often go unnoticed, or somehow deemed as ‘odd’ or one-time phenomena – for instance the fact that the 2016 US elections delivered a Trump administration with full and public backing by a significant part of the Evangelical movement (many of whom are backing a potential comeback of him now); or the fact that related Evangelical counterparts backed Bolsenaro’s rise to power in Brazil; or the fact that religious arguments against abortion remain a key US electoral feature for decades; or the fact that a number of right-leaning anti-immigrant political discourses and blatant white supremacist politics have religious backing in parts of Europe and Latin America.

Was it perhaps that since these took place in ‘white’ and Christian-majority polities, somehow set these aside from being factored as part of the global resurgence of religious politics?

Whatever the case may be, it is time to smell that particularly strong brew of coffee, now. And as we do so, we are also obliged to note that it is no coincidence that this ‘brew’ is taking place at a time of remarkable social and political polarisation in many societies.

Indeed. we speak of multiple and simultaneous crisis (e.g. climate change, catastrophic governance, wars, famines, rampant inequalities, soaring human displacement, nuclear fears, systemic racism, rising multiple violence, drug wars, proliferation of arms and weapons, misogyny, etc.) and we also acknowledge the wilting multilateral influence to confront these. But as we acknowledge these, we must also recognise that social cohesion is a lasting and tragic victim.

Some governmental, non-governmental and intergovernmental entities have turned to religion(s) as a possible panacea. Religious leaders are being convened in multiple capitals (at significant cost) in almost all corners of the world.

Regularly touting the peacefulness and the unparalleled supremacy of their respective moral standpoints. Religious NGOs are being sought out, supported and partnered with more regularly to help address multiple crisis – especially humanitarian, educational, public health, sanitation, and child-focused efforts.

Interfaith initiatives are competing among each other, and with other secular ones, for grants from governments and philanthropists in the United States, Europe, Africa, many parts of Asia (with the notable exception of China), and the Middle East. Engaging, or partnering with religious entities is the new normal.

But just as the largely secular efforts we lived through (and some of us served for decades) in the 1960s to the 1990s, did not realise a brave new world, religious ones, on their own, cannot do so either. Especially not with the kind of historical baggage and contemporary narratives of holy war, we are living with now.

It is time we re-consider, re-engage and re-envision a poetics of solidarity rooted an abiding adherence to (and re-education about) all human rights for all peoples at all times. What would that entail?

1 https://www.theatlantic.com/past/docs/issues/88aug/obrien.htm
2 Connor O’Brian, https://www.livelaw.in/pdf_upload/routes-of-wrath-report-2023-2-465217.pdf
3 Connor O’Brian, https://www.livelaw.in/pdf_upload/routes-of-wrath-report-2023-2-465217.pdf

Part 2 follows.

Dr. Azza Karam is President and CEO of Lead Integrity; a Professor and Affiliate with the Ansari Institute of Religion and Global Affairs at Notre Dame University; and a member of the UN Secretary General’s High Level Advisory Board on Effective Multilateralism.

IPS UN Bureau

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

Violent Deaths by “Small Arms & Light Weapons”: UN Chief’s Warning Dead on Target

Empty large calibre bullet casings on the floor of a heavy machine gun position of the African Union Mission in Somalia (AMISOM) at Kismayo International Airport in southern Somalia. Credit: UN Photo/Ramadaan Mohamed

By Thalif Deen
UNITED NATIONS, Jun 24 2024 – Perhaps two of the biggest misnomers in military jargon are “small arms” and “light weapons” which are the primary weapons of death and destruction in ongoing civil wars and military conflicts, mostly in Asia, the Middle East and Africa.

In a statement last week, at the opening session of the Fourth Review Conference of the Programme of Action on Small Arms and Light Weapons (SALW), UN Secretary-General Antonio Guterres was dead on target when he said there is nothing “small” or “ight” about the damage these weapons cause.

“Small arms and light weapons play a major role in these conflicts. Small arms are the leading cause of violent deaths globally, and are the weapon of choice in nearly half of all global homicides,” Guterres said.

The UN Programme of Action (UNPoA) on small arms and light weapons has an ambitious goal – to “prevent, combat, and eradicate the illicit trade in small arms and light weapons in all its aspects.” But it’s a tough assignment in a political world dominated by the gun lobby and the military-industrial complex.

During the weeklong meeting, scheduled to conclude June 28, diplomats from around the world will review its implementation — against the backdrop of a political agreement that originated back in 2001. Members of civil society are also on hand to present their analyses and lobby and inform governments.

Speaking on behalf of Guterres, UN Under-Secretary-General and High Representative for Disarmament Affairs Izumi Nakamitsu told delegates global military expenditures are on the rise.

And countries, regions and communities across the globe are suffering. New and protracted conflicts are placing millions of people in the line of fire.

“They aggravate crime, displacement and terrorism. From conflict zones to homes, they are used to threaten and perpetrate sexual and gender-based violence”.

According to the UN, “light weapons,” are primarily, weapons designed for use by two or three persons serving as a crew, although some may be carried and used by a single person.

They include, heavy machine guns, handheld under-barrel and mounted grenade launchers, portable anti-aircraft guns, portable anti-tank guns, recoilless rifles, portable launchers of antitank missile and rocket systems, portable launchers of anti-aircraft missile systems, and mortars of a calibre of less than 100 millimetres.

The current civil wars, where the choice of weapons is largely small arms and light weapons, are primarily in Afghanistan, Myanmar, the Central African Republic, the Democratic Republic of the Congo, Haiti, Libya, Mali, Somalia, Sudan, South Sudan and Yemen—besides the two ongoing major wars in Ukraine and Gaza.

But in these two devastating conflicts, the Russians and Israelis are using more sophisticated weapons, including fighter aircraft, combat helicopters, drones, air-to-surface missiles, armoured personnel carriers and battle tanks, among others.

Dr. Natalie J. Goldring, who represents the Acronym Institute for Disarmament Diplomacy in her work at the United Nations on conventional weapons and arms trade issues, told IPS there are many obstacles to the full implementation of the UNPoA, both during the Review Conference and beyond. Two sets of these obstacles seem particularly noticeable at this year’s Review Conference.

The first set of obstacles is external.

In the end, the UNPoA is a political document, designed to be implemented primarily at the national level. States must have the political will to carry out the commitments in the UNPoA and the outcome documents of the various biennial meetings of states and review conferences, she said.

Smaller, less well-resourced States may also need financial assistance to be able to implement some portions of the UNPoA.

As a result, some smaller States are unwilling to accept programs and policies they fear will cost them money to implement, even with the potential availability of international assistance, Dr Goldring pointed out.

“The political challenge is complicated by the major roles played by the arms industry. Weapons manufacturers have financial incentives to sell as many weapons as they can. And States that supply weapons can be dependent on the power of those manufacturers. Some of these manufacturers are so intent on protecting their profits that they even attend, speak, and lobby at these conferences”.

The second key obstacle, she said, is internal.

“The Programme of Action process generally runs on a practice of “consensus”. In theory, that sounds laudable – why wouldn’t we want the process to be dominated by reaching consensus? But in this process, consensus is effectively defined as unanimity. That means that a single negative voice can block change – or progress”.

Because of the consensus process, she argued, these conferences and meetings often face an uncomfortable choice between two main options. One possibility is a strong outcome document, reached through votes, but lacking consensus. Another possibility is a weaker outcome document, reached through consensus.

“If it seems as though consensus is not going to be possible, then the supporters of the UNPoA could – and arguably should – construct an ambitious outcome document that would better fulfill the promise of the UNPoA and would require votes on some of the most controversial paragraphs. Arguably, the worst outcome would be for the proponents of a robust UNPoA to accept a lot of compromises on the text and still not reach consensus,” declared Dr Goldring

Guterres said small arms and light weapons aggravate crime, displacement and terrorism. From conflict zones to homes, they are used to threaten and perpetrate sexual and gender-based violence.

They block vital humanitarian aid from reaching the most vulnerable. They put the lives of United Nations peacekeeping forces and civilian personnel at risk.

And the situation is growing worse, as new developments in the manufacturing, technology and design of small arms — such as 3D printing — make their illegal production and trafficking easier than ever before, warned Guterres.

Rebecca Peters, Director, International Action Network on Small Arms (IANSA), said in an oped piece in the UN Chronicle, that a thousand people die each day from gunshot wounds, and three times as many are left with severe injuries. If the death, injury and disability resulting from small arms were categorized as a disease, it would qualify as an epidemic.

Yet the media and popular perception tend to suggest that gun violence is simply an unavoidable consequence of human cruelty or deprivation, rather than a public health problem which can be prevented or at least reduced, she said.

“The circumstances of gun violence vary so enormously, it would be simplistic to suggest a single solution. A comprehensive approach, reflecting the multi-faceted nature of the problem, is needed to bring down the grim toll of global death and injury.”

Nonetheless, the high school massacres in the US, the armed gangs in Brazil or the systematic sexual violence in the Democratic Republic of the Congo all share a common denominator: the availability of guns (or small arms, as they are known in UN circles).

She said practical steps toward reducing the availability and misuse of small arms can be classified under four headings:

    1. Reducing the existing stockpile
    2. Reducing the supply of new weapons
    3. Closing the gates between the legal and illegal markets
    4. Reducing the motivation for acquiring guns (demand)

Elaborating further, Dr Goldring said the issue of whether or how to include ammunition in the UNPoA is a key example of the difficulty of reaching consensus. This has been the case since the initial negotiation of the UNPoA, when the United States and a few others States showed their willingness to block consensus over this issue. That fight continues at this meeting.

The President of the Review Conference, she said, is a remarkably able diplomat from Costa Rica, Permanent Representative Maritza Chan Valverde. If anyone can thread the needle on having a strong outcome document and reaching consensus at the same time, it’s likely to be Ambassador Chan. But it’s a herculean task.

“I greatly admire her skill and dedication, but I think that the chasm between the supporters of the UNPoA and the obstructionists may simply be too large.”

In discussing the outcome document of the September 2024 Summit of the Future, Ambassador Chan said, “The Pact for the Future cannot remain anchored in the language of the past. Consensus must be forged, not found. Ambition must prevail in the text, and the progress of the many cannot be hindered by the reservations of the few.”

That quote, Dr Goldring said, seems to suggest that she would be willing to have votes in order to avoid having the document be undermined by the obstructionists. But only time will tell.

In the early- to the mid-90s, the international trade in small arms and light weapons was a specialist topic within an extremely small community internationally, and was not on the international policy agenda in a significant way.

Because of the work of analysts and advocates to bring attention to this issue, subsequently accompanied by the work of dedicated diplomats at the UN and elsewhere, it is now an established part of international work to reduce the human costs of armed violence.

“Unfortunately, quantitative measures of the UNPoA’s effectiveness are difficult – if not impossible — to develop. Instead, we often measure outputs and activities, rather than outcomes. We simply don’t know the counterfactual – what the situation would have been without the UNPoA,” she declared.

Thalif Deen is a former Director, Foreign Military Markets at Defense Marketing Services; Senior Defense Analyst at Forecast International; and Military Editor Middle East/Africa at Jane’s Information Group.

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

amana Appoints Jack Saidy as Director of Operations in Lebanon

BEIRUT, June 24, 2024 (GLOBE NEWSWIRE) — amana, a leading MENA neobroker, has appointed Jack Saidy as Director of Operations to spearhead its operations in Lebanon, marking a significant milestone in the company's expansion strategy.

Jack Saidy has a strong track record of leadership in financial markets. Previous to joining amana, he held a Director role at Advanced Markets focused on training sales teams and engaging with customers, building his understanding of how to best serve customers in Lebanon and the MENA region. His career in the financial markets spans over 12 years, including a management role at Tickmill, and a previous VP role at amana. His return to amana has been celebrated by the team and allowed for seamless integration into the work culture.

Jack Saidy: “amana offers a premium product with top–notch customer service, support, and ethical trading, filling a market gap in Lebanon. amana allows customers to trade all markets on their platform of choice (app, web, META), while providing 24/6 customer support from our office in downtown Beirut. Regulated by multiple entities including CMA, amana takes additional measures beyond regulatory requirements to promote fair and ethical trading. From highlighting leveraged assets to providing world–class education for free within the app, amana promotes healthy trading and investing practices for the long–term benefit of its customers. This makes me proud to help bring amana to our customers in Lebanon, and fill this market gap.”

amana offers over 5,500 assets on its platforms, allowing customers to trade both physical and leveraged US and MENA shares, commodities, currencies, and more. On amana you can also trade fractional shares of US and MENA stocks.

CEO Muhammad Rasoul: “Hiring Jack and expanding our Lebanon office is a sign of our investment in Lebanon, and our commitment to ensuring our Lebanon customers are getting the level of service they deserve.”

About amana

amana is a leading neobroker in the Middle East. It provides active traders and investors across MENA with direct access to the global and regional financial markets. It operates multiple offices, such as in Beirut, Dubai, and Limassol.

amana is regulated by DFSA in the UAE, the FCA in the UK, CYSEC in Europe, the CMA in Lebanon, the LFSA in Malaysia, and the FSC in Mauritius.

www.amana.app

Contact: Karolina Slowikowska, Director of Communications (karolina.slowikowska@amanacapital.com)

Photo:

https://www.globenewswire.com/NewsRoom/AttachmentNg/90384623–94c2–4f7a–987a–a20bd77ab16d


GLOBENEWSWIRE (Distribution ID 1000967915)

أمانة تعيّن جاك سعيدي مديراً للعمليات في لبنان

بيروت, June 24, 2024 (GLOBE NEWSWIRE) — قامت شركة أمانة، التي تعد من إحدى الشركات الرائدة في مجال الوساطة المالية الإلكترونية في منطقة الشرق الأوسط وشمال أفريقيا، بتعيين جاك سعيدي مديراً للعمليات لقيادة عملياتها التجارية في لبنان، وهي ما تعد خطوة مهمة للغاية فيما يتعلق باستراتيجية الشركة التوسعية.

لدى جاك سعيدي سجل حافل من الخبرة في الأسواق المالية. قبيل انضمامه إلى أمانة، شغل جاك منصب مدير في شركة “أدفانسد ماركت” حيث كان تركيزه على تدريب فريق المبيعات والتواصل مع العملاء، إضافة إلى العمل على كيفية تقديم أفضل خدمة للعملاء في لبنان ومنطقة الشرق الأوسط وشمال أفريقيا. وتمتد مسيرته المهنية في الأسواق المالية لأكثر من 12 عامًا، بما في ذلك دور إداري في شركة Tickmill، إضافة إلى منصب نائب الرئيس السابق في أمانة. وقد احتفل الفريق بعودته إلى أمانة مما أدى إلى سهولة الاندماج في بيئة العمل المحيطة.

وقد صرّح جاك سعيدي: “تسد أمانة فجوة في السوق اللبناني عبر توفير خدمة عملاء ودعم وتداول أخلاقي من الدرجة الأولى. تسمح أمانة للعملاء بالتداول في جميع الأسواق على أي منصة من اختيارهم (التطبيق، الويب، ميتا META)، مع توفير دعم للعملاء على مدار 24 ساعة، ستة أيام في الأسبوع، من مكتبنا في بيروت. وتخضع أمانة لتنظيم العديد من الجهات، بما في ذلك هيئة السوق المالية (CMA)، وتتخذ تدابير إضافية تتجاوز المتطلبات التنظيمية لتعزيز التداول العادل والأخلاقي. بدءًا من تسليط الضوء على الأصول ذات الرافعة المالية وتوفير تعليم عالمي المستوى مجانًا داخل التطبيق، تعمل أمانة على تعزيز ممارسات التداول والاستثمار الصحية لتحقيق المنفعة طويلة المدى لعملائها. وهذا ما يجعلني اشعر بالفخر للمساعدة في دخول أمانة إلى عملائنا في لبنان، وسد هذه الفجوة في السوق”.

تقدم أمانة أكثر من 5500 أصل على منصاتها، مما يسمح للعملاء بالتداول الفعلي والأسهم ذات الرافعة المالية في الولايات المتحدة ومنطقة الشرق الأوسط وشمال إفريقيا والسلع والعملات والمزيد. في أمانة، يمكنك أيضًا تداول أسهم كسرية من الأسهم الأمريكية ومنطقة الشرق الأوسط وشمال أفريقيا.

وتعليقا على الحدث، قال محمد رسول، الرئيس التنفيذي لشركة أمانة: إن تعيين جاك وتوسيع مكتبنا في لبنان هو علامة على استثمارنا في لبنان، والتزامنا بضمان حصول عملائنا في لبنان على مستوى الخدمة التي يستحقون”.

عن أمانة

أمانة هي شركة وساطة إلكترونية رائدة في الشرق الأوسط. والتي توفر للمتداولين والمستثمرين في جميع أنحاء منطقة الشرق الأوسط وشمال أفريقيا إمكانية الوصول المباشر إلى الأسواق المالية العالمية والإقليمية. ولدى الشركة مكاتب متعددة، في بيروت ودبي وليماسول.

تخضع شركة أمانة للرقابة من قبل سلطة دبي للخدمات المالية (DFSA) في الإمارات العربية المتحدة، وهيئة السلوك المالي (FCA) في المملكة المتحدة، وهيئة الأوراق المالية والبورصة القبرصية (CYSEC) في أوروبا، وهيئة السوق المالية (CMA) في لبنان، وهيئة الأوراق المالية والبورصة القبرصية (CYSEC) في أوروبا، وهيئة لابوان للأوراق المالية (LFSA) في ماليزيا، وهيئة الخدمات المالية (FSC) في موريشيوس.

www.amana.app

للتواصل: كارولينا سلويكوسكا، مديرة الاتصالات 

(karolina.slowikowska@amanacapital.com)

الصورة المصاحبة لهذا الإعلان متاحة على

https://www.globenewswire.com/NewsRoom/AttachmentNg/90384623–94c2–4f7a–987a–a20bd77ab16d 


GLOBENEWSWIRE (Distribution ID 1000967915)

OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

London, June 24, 2024 (GLOBE NEWSWIRE) — June 24, 2024, London, UK – OPEN Health, a pre–eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine learning (ML) solutions provider that will work exclusively with OPEN Health. This alliance will see fusion's market–leading AI capabilities deployed across OPEN Health's extensive global client base, which includes 49 of the top 50 pharmaceutical companies.

Mary McGregor, Founder of fusion, commented, “OPEN Health provides an unrivalled platform to expand the AI agenda globally in our sector. Our longstanding relationship with OPEN Health leadership facilitated early conversations, enabling us to quickly market–test joint solutions, which led to a swift and unanimous decision to formalize this collaboration. This partnership empowers us to redefine the boundaries of what AI can accomplish in healthcare.”

Margot Hannah,  Chief Executive Officer of Scientific Communications at OPEN Health, expressed her enthusiasm for the partnership: “We immediately recognized the need to expand our capabilities and started a dialog with fusion about an exclusive partnership to provide pioneering solutions that integrate OPEN Health’s capabilities with fusion’s cutting–edge expertise in AI and ML. Fusion’s expertise in this area is unparalleled, and we are excited about the possibilities this partnership brings for our clients.”

Steve Duryee, Chief Operating and Transformation Officer at OPEN Health, added, “We are committed to harnessing the power of cutting–edge technologies, including AI, ML, robotic process automation, and data analytics, to drive higher value and improved outcomes for our clients. With the recent launch of our Solutions Innovation Center, and the addition of fusion to our extended team of elite–level technology partners, we are now in the pole position to deliver the most innovative, technologically advanced solutions to our biopharmaceutical partners.”

By integrating with fusion’s advanced technology, OPEN Health underscores its commitment to leading the AI agenda with socially beneficial innovations to drive innovation and efficiency for clients. Contact OPEN Health to set up an interactive demonstration at www.openhealthgroup.com/contact–us.

About OPEN Health
OPEN Health unites world–class scientific, strategic, and creative expertise to solve complex challenges for global biopharma. We are a flexible, global organization, creating high–performing strategic partnerships with our clients. We embrace our different perspectives and strengths to deliver innovative solutions that have a positive impact on commercial and patient outcomes. OPEN Health unlocks possibilities across consulting, HEOR and market access, scientific communications, and patient engagement. To learn more, visit www.openhealthgroup.com.

About fusion
fusion specializes in delivering AI and ML solutions. Known for its advanced technology and innovative approach, fusion aims to transform the pharmaceutical industry by integrating AI–first solutions. To learn more, visit www.fusionagency.solutions.

Attachment


GLOBENEWSWIRE (Distribution ID 9157597)

Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa

Saint–Louis, France and Weil am Rhein, Germany and Zurich, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) — Allecra Therapeutics (“Allecra”) and Acino today announced the signing of an exclusive licensing agreement under which Acino gains the rights to commercialise Allecra’s antibiotic drug EXBLIFEP® (cefepime/enmetazobactam) within the Republic of South Africa and the member states of the GCC alliance, which includes Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates, effective from 12 June 2024. In addition, the companies have signed a supply agreement under which Allecra will supply the cefepime/enmetazobactam finished product in the above territories.

“Acino has established itself as a leader in South Africa and the GCC region. They are an ideal partner to support us as we build towards commercialisation of EXBLIFEP® following our regulatory approvals in the US and EU,” stated Andreas Kranzusch, Chief Financial Officer and Managing Director at Allecra Therapeutics. “This agreement reflects the understanding that there remains a significant global need to address the dangerous increase of resistance to standard–of–care antibiotics, and we look forward to working with Acino to address this.”

“At Acino, we are dedicated to providing novel healthcare solutions to physicians and patients, aiming to alleviate the health burden in emerging markets. We are incredibly excited to partner with Allecra to offer access to this innovative product in two key geographic regions and, potentially, beyond,” said Andrew Bird, CEO (ai) at Acino. “We are committed to expediting the registration process in these designated markets to ensure hospitals’ swift access to EXBLIFEP® as they continue to fight against high–risk infectious diseases in patients.”

About EXBLIFEP® (cefepime/enmetazobactam)

EXBLIFEP® is an intravenous antibiotic fixed–dose combination of enmetazobactam, a novel extended–spectrum β–lactamase inhibitor belonging to the penicillanic acid sulfone class, with the fourth–generation cephalosporin cefepime. Enmetazobactam has been shown to restore the efficacy of cefepime against some multi–drug resistant bacteria, including ESBL–producing pathogens alone or in combination with some resistant β–lactamase mutations as OXA–48 or AmpC, which are increasing in Europe and for which there are few therapeutic alternatives.

EXBLIFEP® demonstrated statistically significant superior overall treatment success in Allecra’s pivotal Phase III ALLIUM trial, which compared 1034 randomized patients receiving either cefepime 2 g/enmetazobactam 0.5 g or piperacillin 4 g/tazobactam 0.5 g every 8 h as 2 h continuous intravenous infusion in a multi–centre, randomized, controlled, double–blind, global study in 112 sites within nineteen countries.

In February 2024, the U.S. Food and Drug Administration (FDA) approved EXBLIFEP® as a treatment for complicated urinary tract infections (cUTI), including pyelonephritis, in patients 18 years and older. In March 2024 the European Commission (EC) granted marketing authorisation for EXBLIFEP® for the treatment of adult patients with cUTI, including pyelonephritis; hospital–acquired pneumonia (HAP), including ventilator–associated pneumonia (VAP); and bacteraemia that occurs in association with, or is suspected to be associated with any of the infections listed previously.

About Allecra Therapeutics

Allecra Therapeutics, founded in 2013, is a private, clinical–stage biopharmaceutical company developing novel therapies to combat antibiotic resistance by overcoming emergent resistance mechanisms. Lead product candidate EXBLIFEP® (cefepime/enmetazobactam), has successfully completed a randomized, controlled, double–blind, global Phase 3 trial compared to standard of care in patients with complicated urinary tract infections (cUTIs). Based on these results, the company has received FDA marketing approval in the U.S. and announced approval in the European Union for EXBLIFEP® earlier this year.

Allecra has significant patent protection covering proprietary enmetazobactam in major territories. Allecra’s investors include Forbion, Andera Partners, Delos Capital, Xeraya Capital, EMBL Ventures, and BioMedPartners. Allecra’s wholly owned French subsidiary is a beneficiary of financial support from Bpifrance and the Région Alsace. Please visit www.allecra.com for further information.

About Acino

Acino is a Swiss pharmaceutical company headquartered in Zurich with a clear focus on selected markets in the Middle East, Africa, Ukraine, the CIS Region, and Latin America. We deliver quality pharmaceuticals to promote affordable healthcare in these emerging markets and leverage our high–quality pharmaceutical manufacturing capabilities and network to supply leading companies through contract manufacturing and out–licensing. For more information, please visit www.acino.swiss.

Acino is part of Arcera, a global company in the life sciences sector headquartered in Abu Dhabi, United Arab Emirates. Arcera was established by ADQ, an Abu Dhabi–based investment and holding company, to build a global life sciences powerhouse poised to make significant contributions to realising the UAE’s aspiration to emerge as a frontrunner in science and technology. To learn more about Arcera, please visit www.arceralifesciences.com.

Attachments


GLOBENEWSWIRE (Distribution ID 9157528)

Notice of Proposed Settlement and Plan of Allocation Involving Purchasers of Perrigo Common Stock from April 21, 2015 through May 2, 2017 and Owners of Perrigo Common Stock as of November 12, 2015

SEATTLE, June 24, 2024 (GLOBE NEWSWIRE) —

UNITED STATES DISTRICT COURT
DISTRICT OF NEW JERSEY

ROOFER’S PENSION FUND, on behalf of
itself and all others similarly situated,

                        Plaintiff,

        v.

JOSEPH C. PAPA, et al.,

                        Defendants

Case No. 1:16–cv–02805–RMB–LDW

CLASS ACTION


SUMMARY NOTICE OF (I) PROPOSED SETTLEMENT

AND PLAN OF ALLOCATION; (II) SETTLEMENT HEARING; AND
(III) MOTION FOR ATTORNEYS’ FEES AND LITIGATION EXPENSES

To: (1) All persons who purchased Perrigo Company plc’s (“Perrigo”) publicly traded common stock between April 21, 2015 and May 2, 2017, both dates inclusive (the “Class Period”), on the New York Stock Exchange or any other trading center within the United States and were damaged thereby;

(2) All persons who purchased Perrigo’s publicly traded common stock between April 21, 2015 and May 2, 2017, both dates inclusive, on the Tel Aviv Stock Exchange and were damaged thereby; and

(3) All persons who owned Perrigo common stock as of November 12, 2015 and held such stock through at least 8:00 a.m. on November 13, 2015 (whether or not a person tendered their shares in response to the tender offer of Mylan, N.V”).¹


PLEASE READ THIS NOTICE CAREFULLY; YOUR RIGHTS WILL BE AFFECTED BY THE SETTLEMENT OF A CLASS ACTION LAWSUIT PENDING IN THIS COURT.

YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the District of New Jersey, that the Court–appointed Lead Plaintiff, on behalf of itself and the Court–certified Class, in the above–captioned securities class action (the “Action”) has reached a proposed settlement of the Action with defendants Perrigo Company plc (“Perrigo”) and Joseph C. Papa (collectively, “Defendants”) for $97,000,000 in cash that, if approved, will resolve all claims in the Action.

A hearing will be held on September 5, 2024 at 10:00 a.m., before the Honorable Leda Dunn Wettre, United States Magistrate Judge, in person in Courtroom 3C of the Martin Luther King Building & U.S. Courthouse, 50 Walnut Street, Newark, NJ 07101, to determine: (i) whether the proposed Settlement should be approved as fair, reasonable, and adequate; (ii) whether the Action should be dismissed with prejudice against Defendants, and the releases specified and described in the Stipulation and Agreement of Settlement dated April 4, 2024 should be granted; (iii) whether the proposed Plan of Allocation should be approved as fair and reasonable; and (iv) whether Lead Counsel’s application for an award of attorneys’ fees and payment of expenses should be approved.

If you are a member of the Class, your rights will be affected by the pending Action and the Settlement, and you may be entitled to share in the Net Settlement Fund. If you have not yet received the full printed Notice of (I) Proposed Settlement and Plan of Allocation; (II) Settlement Hearing; and (III) Motion for Attorneys’ Fees and Litigation Expenses (the “Settlement Notice”) and the Claim Form, you may obtain copies of these documents by contacting the Claims Administrator at Perrigo Securities Litigation, c/o JND Legal Administration, P.O. Box 91374, Seattle, WA 98111, 1–833–674–0175, info@PerrigoSecuritiesLitigation.com. Copies of the Settlement Notice and Claim Form can also be downloaded from the website for the Action, www.PerrigoSecuritiesLitigation.com.

If you are a Class Member, in order to be eligible to receive a payment under the proposed Settlement, you must submit a Claim Form online or postmarked no later than August 26, 2024. If you are a Class Member and do not submit a proper Claim Form, you will not be eligible to share in the distribution of the net proceeds of the Settlement but you will nevertheless be bound by any judgments or orders entered by the Court in the Action.

Any objections to the proposed Settlement, the proposed Plan of Allocation, and/or Lead Counsel’s application for attorneys’ fees and payment of expenses, must be filed with the Court and delivered to Lead Counsel and counsel for Defendants such that they are received no later than August 6, 2024, in accordance with the instructions set forth in the Settlement Notice.

Please do not contact the Court, the Clerk’s office, Perrigo, any other Defendant in the Action, or their counsel regarding this notice. All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed the Claims Administrator or Lead Counsel.

Requests for the Settlement Notice and Claim Form should be made to:

Perrigo Securities Litigation
c/o JND Legal Administration
P.O. Box 91374
Seattle, WA 98111
1–833–674–0175
info@PerrigoSecuritiesLitigation.com
www.PerrigoSecuritiesLitigation.com

Inquiries, other than requests for the Settlement Notice and Claim Form, may be made to Lead Counsel:

Pomerantz LLP
Joshua Silverman
10 S. LaSalle Street
Chicago, IL 60603
1–312–377–1181
jbsilverman@pomlaw.com

Bernstein Litowitz Berger & Grossmann LLP
James A. Harrod
1251 Avenue of the Americas
New York, NY 10020
1–800–380–8496
settlements@blbglaw.com

By Order of the Court

________________________________
¹ Certain persons and entities are excluded from the Class by definition and others are excluded pursuant to request. The full definition of the Class including a complete description of who is excluded from the Class is set forth in the full Settlement Notice referred to above.


GLOBENEWSWIRE (Distribution ID 9154224)